"Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity" by R G Steis

Selected Works of Walter J. Urba, MD, PhD

Article

Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity

Journal of Clinical Oncology (1990)

R G Steis, National Institutes of Health
W J Urba, National Institutes of Health
L A VanderMolen, National Institutes of Health
M A Bookman, Fox Chase Cancer Center
J W Smith nd, National Institutes of Health
J W Clark, Harvard University
R L Miller
E D Crum
S K Beckner
J E McKnight

Link

Disciplines

Medicine and Health Sciences and
Pathology

Publication Date

January 10, 1990

DOI

10.1200/JCO.1990.8.10.1618

Citation Information

R G Steis, W J Urba, L A VanderMolen, M A Bookman, et al.. "Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity" Journal of Clinical Oncology Vol. 8 Iss. 10 (1990) p. 1618 - 1629
Available at: http://works.bepress.com/walter-urba/64/